OOIR: Observatory of International Research

Papers

(The H4-Index of Kidney International is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
In This Issue	3437
Table of Contents	1040
Subscription Information	568
Taking the A(llorecognition) train: connecting passenger T cells to DSA	368
in this issue	326
Thirsty encounters of the third kind	307
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	300
Title Page	266
Editorial Board	249
Editorial Board	200
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	166
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	163
Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors	159
Seeing through the density of dense deposit disease	138
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner	121
Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence	119
Kidney supportive care: every nephrologist’s business	116
Blood pressure adaptation in vertebrates: comparative biology	116
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality	115
Identification of the gut microbial enzyme turning the urine yellow	114
A pig kidney supporting human physiology	113
Challenges in the development of novel methodologies for measuring glomerular filtration rate	110
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage	107
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	106
Autoimmunoglobulin-triggered extracellular vesicles as new players in membranous nephropathy: friends or foes?	102

Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	101
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect	101
Unlocking the full potential of human pluripotent stem cell–derived kidney organoids through bioengineering	90
Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis	88
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	83
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function	82
Gene editing: a near future for the treatment of genetic kidney diseases	78
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	78
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	76
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	75
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody–induced crescentic glomerulonephritis	75
Editorial Board	74
Giving monocytes their due: how CD47–SIRP-α reframes allograft rejection	73
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)	73
The Case \| Progressive submandibular mass and nephrotic syndrome in a young man	71
The authors reply:	70
Monoclonal immunoglobulin crystalline nephropathies	68
Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?	68
The single-cell landscape of the human vein after arteriovenous fistula creation and implications for maturation failure	68
New advances in endocrine hypertension: from genes to biomarkers	67
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies	66
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	66
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	66
Felzartamab: a magic bullet to treat microvascular rejection?	64
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis	63
Editorial Board	62
Erdheim-Chester disease: hairy kidney and coated aorta	61
To do or not to do—genetic testing for autosomal dominant polycystic kidney disease in children and adolescents	60
Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures	60
The T-cell environment: may the regulatory force be with you	59
Crystal-induced colitis	58
Letter to the Editor	58
Immunoaging within the kidney via injury-associated tertiary lymphoid tissue	58